| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |